How effective is Cannabis for Attention Deficit Hyperactivity Disorder? (a real world drug study)
Summary:
Overall ratings: 3.3/5 Long term ratings: 3.4/5
This is a phase IV clinical study of how effective Cannabis (marijuana) is for Attention deficit hyperactivity disorder and for what kind of people. The study is created by eHealthMe from 16 Cannabis users and is updated continuously.
What is Cannabis?
Cannabis has active ingredients of marijuana. It is often used in stress and anxiety. eHealthMe is studying from 13,371 Cannabis users. Check the latest studies of Cannabis.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 609 drugs and 1,393 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
16 people are studied for taking Cannabis in Attention deficit hyperactivity disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Cannabis effectiveness for Attention deficit hyperactivity disorder (number of people):
Overall:
- not at all: 0
- somewhat: 2
- moderate: 8
- high: 5
- very high: 1
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 5
- high: 3
- very high: 1
Gender of people who take Cannabis for Attention deficit hyperactivity disorder *:
- female: 25 %
- male: 75 %
Age of people who take Cannabis for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 31.25 %
- 20-29: 25.0 %
- 30-39: 18.75 %
- 40-49: 18.75 %
- 50-59: 6.25 %
- 60+: 0.0 %
Who find Cannabis more effective for Attention Deficit Hyperactivity Disorder?
Gender of people who take Cannabis for Attention deficit hyperactivity disorder *:
- female: 33.33 %
- male: 66.67 %
Age of people who take Cannabis for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 33.33 %
- 20-29: 16.67 %
- 30-39: 33.33 %
- 40-49: 16.67 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Cannabis?
- You can start a phase IV clinical trial to monitor Cannabis safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Cannabis (13,371 reports)
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (120,336 reports)
How the study uses the data?
The study is based on marijuana (the active ingredients of Cannabis) and Cannabis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Vitamin D3 and Vicodin Es - 2 seconds ago
- Could Everolimus cause Movement - Uncoordinated? - 5 seconds ago
- Zestril vs. Hytrin, side effect and effectiveness comparison - 7 seconds ago
- Drug interactions of Cisplatin and Zantac - 8 seconds ago
- Could B12 cause Emergency Care? - 17 seconds ago
- Could Neurontin cause Exposed Bone In Jaw? - 17 seconds ago
- Complera vs. Kaletra, side effect and effectiveness comparison - 28 seconds ago
- Could Lovaza cause Pleural Fibrosis? - 31 seconds ago
- Could Naproxen Sodium cause Duodenal Ulcer Aggravated? - 38 seconds ago
- Could Ramipril cause Impaired Driving Ability? - 40 seconds ago